Is LRIG1 a tumour suppressor gene at chromosome 3p14.3?

被引:81
作者
Hedman, H [1 ]
Nilsson, J [1 ]
Guo, DS [1 ]
Henriksson, R [1 ]
机构
[1] Univ Umea Hosp, Dept Radiat Sci & Oncol, S-90185 Umea, Sweden
关键词
D O I
10.1080/028418602760169398
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The LRIG1 gene (formerly LIG-1), recently cloned by us, displays structural similarities to the Drosophila Kek 1 gene. Kek 1 encodes a cell surface protein, Kekkon-1, which inhibits epidermal growth factor receptor-mediated signalling. We localized the LRIG1 gene to chromosome band 3p14.3, a region known to be deleted in various human cancers. In the present study LRIG1 gene expression was examined in different tumour cell lines and corresponding normal tissues by real-time RT-PCR. In many tumour cell lines, LRIG1 expression appeared absent or was down regulated compared to corresponding normal tissues. The results are consistent with LRIG1 being a tumour suppressor gene in humans. However, further studies are justified to elucidate the explicit role of LRIG1 as a negative regulator of oncogenesis.
引用
收藏
页码:352 / 354
页数:3
相关论文
共 8 条
  • [1] The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis
    Ghiglione, C
    Carraway, KL
    Amundadottir, LT
    Boswell, RE
    Perrimon, N
    Duffy, JB
    [J]. CELL, 1999, 96 (06) : 847 - 856
  • [2] DNA copy number losses in human neoplasms
    Knuutila, S
    Aalto, Y
    Autio, K
    Björkqvist, AM
    El-Rifai, W
    Hemmer, S
    Huhta, T
    Kettunen, E
    Kiuru-Kuhlefelt, S
    Larramendy, ML
    Lushnikova, T
    Monni, O
    Pere, H
    Tapper, J
    Tarkkanen, M
    Varis, A
    Wasenius, VM
    Wolf, M
    Zhu, Y
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) : 683 - 694
  • [3] MITTELMAN F, 2001, MITTELMAN DATABASE C
  • [4] The Drosophila kekkon genes: Novel members of both the leucine-rich repeat and immunoglobulin superfamilies expressed in the CNS
    Musacchio, M
    Perrimon, N
    [J]. DEVELOPMENTAL BIOLOGY, 1996, 178 (01) : 63 - 76
  • [5] NILSSON J, 2001, BIOCHEM BIOPH RES CO, V284, P31
  • [6] The type III epidermal growth factor receptor mutation - Biological significance and potential target for anti-cancer therapy
    Pedersen, MW
    Meltorn, M
    Damstrup, L
    Poulsen, HS
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (06) : 745 - 760
  • [7] SUZUKI Y, 1996, J BIOL CHEM, V271, P225
  • [8] Yarden Y, 2001, EUR J CANCER, V37, pS3